摘要
目的:分析某院医院住院患者抑酸药的应用情况,为临床合理用药提供参考。方法:随机抽查该院2014年1月至12月期间住院患者抑酸药使用情况,统计抑酸药消耗数量、金额及科室分布,对累积用药频度(DDDs)、使用强度、使用率、年人均费用及使用目的等进行统计分析。结果:住院患者抑酸药品种以质子泵抑制剂(Proton Pump Inhibitors,PPI)占主导地位,主要采用静脉给药。内科系统DDDs占59.18%,主要是消化、呼吸、心内、肾内等;外科占40.82%,主要是普外一科、普外二科和泌外科。使用强度排名,前5位的是消化科、普外一科、普外二科、泌外科和ICU。住院患者使用率为42.00%;人均费用442.17元。结论:PPI在住院患者中使用非常广泛,但存在一定的不合理性,有待规范。
Objective: To analyze the application of the acid-suppressive drugs in the inpatients in one hospital and provide reference for the clinical rational use of drugs. Mothods: Randomized sampling the application of the acid-suppressive drugs in the inpatients monthly from January to December 2014, the consumption quantity, sales amount, department distribution, DDDs, use intensity, utilization rate of acid-suppressive drugs, per capita costs and indications were performed the statistics analysis. Results: The proton pump inhibitors (PPI)were predominant in the acid-suppressive drugs used in inpatients and mainly adopted the intravenous administration. The percentage of use frequency in internal medicine was 59.18%, involving the digestion, respiration, cardiology, nephrology, etc. Surgery was 40.82%, mainly involving 1 st general surgery, 2nd general surgery and urology. The TOP5 of use intensity were digestion, 1st general surgery, 2rid general surgery, urology and ICU. The inpatients' utilization rate was 42.00%. Per capita costs were 442.17 CNY. Conclusions: PPI was used widely in inpatients, but there were some unreasonable aspects need to be standardized.
出处
《药品评价》
CAS
2015年第20期26-29,共4页
Drug Evaluation